Bausch Health Companies Inc. Accounts Payable
Bausch Health Companies Inc. (BHC) had Accounts Payable of $593.00 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-07-30
- 2026-06-30: Accounts Payable, Current $593.00M.
- 2026-03-31: Accounts Payable, Current $593.00M.
- 2025-12-31: Accounts Payable, Current $600.00M.
- 2025-09-30: Accounts Payable, Current $616.00M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $593.00M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $593.00M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $600.00M 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $616.00M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $627.00M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $620.00M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $589.00M 10-K · filed 2026-02-19 | $656.00M 10-K · filed 2025-02-20 |
| 2024-09-30 | $667.00M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $579.00M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $642.00M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $719.00M 10-K · filed 2025-02-20 | |
| 2023-09-30 | $569.00M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $515.00M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $561.00M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $521.00M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $486.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $536.00M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $471.00M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $407.00M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $455.00M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $442.00M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $342.00M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $337.00M 8-K · filed 2022-05-11 | |
| 2020-09-30 | $379.00M 10-Q · filed 2020-11-03 | |
| 2020-06-30 | $447.00M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $444.00M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $503.00M 8-K · filed 2021-05-04 | |
| 2019-09-30 | $437.00M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $527.00M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $429.00M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $411.00M 10-K · filed 2020-02-19 | |
| 2018-09-30 | $440.00M 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $417.00M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $428.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $365.00M 10-K · filed 2019-02-20 | |
| 2017-09-30 | $407.00M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $371.00M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $368.00M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $324.00M 8-K · filed 2018-08-10 | |
| 2016-09-30 | $358.70M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $425.90M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $438.10M 10-Q · filed 2016-06-07 | |
| 2015-12-31 | $434.00M 10-K · filed 2017-03-01 | $433.70M 10-K · filed 2016-04-29 |
| 2015-09-30 | $476.80M 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $415.80M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $352.50M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $398.00M 10-K · filed 2016-04-29 | |
| 2014-09-30 | $323.30M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $327.70M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $392.30M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $327.00M 10-K · filed 2015-02-25 | $326.97M 10-K · filed 2014-02-28 |
| 2013-09-30 | $412.94M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $284.54M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $183.02M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $227.38M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $166.69M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $156.18M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $156.28M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $157.62M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $148.78M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $126.71M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $116.12M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $101.32M 10-K · filed 2012-02-29 | |
| 2010-09-30 | $175.99M 10-Q · filed 2010-11-05 | |
| 2010-06-30 | $41.88M 10-Q · filed 2010-08-06 | |
| 2009-12-31 | $72.02M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |